UK pharmaceutical giant GSK has confirmed that it has signed an agreement to acquire the privately-held biotechnology company IDRx.
The post GSK enters agreement to acquire IDRx for $1.15 Billion to strengthen cancer portfolio appeared first on Nairametrics.
